Key terms

About IFF

International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest IFF news

Mar 27 8:29am ET IFF price target raised to $96 from $89 at Morgan Stanley Mar 21 4:32pm ET Leadership Shuffle at International Flavors & Fragrances Mar 21 2:36am ET Strategic Divestiture and Debt Reduction Bolster Buy Rating for IFF Mar 20 12:15pm ET Strategic Shift and Debt Reduction at IFF: Balancing Hold Rating Amidst EPS Dilution Concerns Mar 20 8:45am ET IFF price target raised to $100 from $90 at Deutsche Bank Mar 20 6:42am ET IFF price target raised to $91 from $83 at Mizuho Mar 20 4:57am ET Strategic Divestiture and Financial Optimization: Buy Rating for International Flavors & Fragrances Mar 20 3:15am ET New Sell Rating for International Flavors & Fragrances (IFF), the Basic Materials Giant Mar 19 11:35am ET Analyst Holds Rating on IFF Post Pharma Solutions Sale Amid Market Anticipation and Conservative Valuation Concerns Mar 19 7:12am ET International Flavors & Fragrances Divests Pharma Solutions Business Mar 19 6:51am ET IFF to sell Pharma Solutions business to Roquette for $2.85B Mar 08 8:17am ET IFF cut to Hold at Argus on higher costs, volume slowdown Mar 08 8:05am ET IFF downgraded to Hold from Buy at Argus Feb 29 6:38pm ET Wolfe starts IFF at Underperform, says valuation in line with higher-end product Feb 29 4:28pm ET IFF initiated with an Underperform at Wolfe Research Feb 28 7:24am ET IFF reports approval of SYNERXIA yeasts in Argentina for biofuel production Feb 26 6:40am ET IFF price target raised to $83 from $82 at Mizuho Feb 22 7:15pm ET Hold Rating on IFF Maintained Amidst Conservative Outlook and Strategic Shifts Feb 22 7:02am ET IFF price target raised to $90 from $85 at Wells Fargo Feb 22 6:56am ET IFF price target raised to $85 from $80 at Baird Feb 22 6:33am ET IFF price target lowered to $81 from $85 at Citi Feb 22 12:46am ET Optimistic Outlook: Buy Rating for IFF Amid Balance Sheet Deleverage and Anticipated Market Recovery Feb 21 8:47am ET IFF price target lowered to $80 from $87 at Stifel Feb 21 8:05am ET Analysts Offer Insights on Materials Companies: Celanese (CE) and International Flavors & Fragrances (IFF) Feb 21 7:05am ET Analysts Offer Insights on Materials Companies: International Flavors & Fragrances (IFF) and Westlake Chemical (WLK) Feb 21 6:50am ET IFF price target lowered to $82 from $86 at Mizuho Feb 21 5:16am ET Buy Rating Affirmed for IFF on Strong Q4 EBITDA and Prudent Financial Strategy Feb 21 4:52am ET International Flavors & Fragrances (NYSE:IFF) Plummets on Dividend Cut, Weak Guidance Feb 21 3:26am ET Buy Rating Affirmed for IFF on Dividend Cut and Strong Operational Performance Feb 20 4:22pm ET IFF discloses $2.6B non-cash goodwill impairment charge Feb 20 4:21pm ET IFF sees FY24 revenue $10.8B-$11.1B, consensus $11.41B

No recent news articles are available for IFF

No recent press releases are available for IFF

IFF Financials

1-year income & revenue

Key terms

IFF Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

IFF Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms